RadNet Gross Profit 2010-2024 | RDNT

RadNet gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
RadNet Annual Gross Profit
(Millions of US $)
2023 $221
2022 $166
2021 $192
2020 $106
2019 $154
2018 $108
2017 $120
2016 $109
2015 $101
2014 $115
2013 $104
2012 $104
2011 $107
2010 $98
2009 $130
RadNet Quarterly Gross Profit
(Millions of US $)
2024-03-31 $44
2023-12-31 $64
2023-09-30 $60
2023-06-30 $59
2023-03-31 $39
2022-12-31 $54
2022-09-30 $36
2022-06-30 $49
2022-03-31 $27
2021-12-31 $48
2021-09-30 $60
2021-06-30 $50
2021-03-31 $33
2020-12-31 $50
2020-09-30 $45
2020-06-30 $-4
2020-03-31 $14
2019-12-31 $45
2019-09-30 $38
2019-06-30 $43
2019-03-31 $28
2018-12-31 $24
2018-09-30 $34
2018-06-30 $34
2018-03-31 $16
2017-12-31 $35
2017-09-30 $29
2017-06-30 $31
2017-03-31 $24
2016-12-31 $33
2016-09-30 $32
2016-06-30 $25
2016-03-31 $20
2015-12-31 $28
2015-09-30 $33
2015-06-30 $28
2015-03-31 $12
2014-12-31 $29
2014-09-30 $31
2014-06-30 $31
2014-03-31 $24
2013-12-31 $30
2013-09-30 $23
2013-06-30 $28
2013-03-31 $23
2012-12-31 $22
2012-09-30 $27
2012-06-30 $29
2012-03-31 $27
2011-12-31 $25
2011-09-30 $25
2011-06-30 $29
2011-03-31 $28
2010-12-31 $6
2010-09-30 $33
2010-06-30 $33
2010-03-31 $26
2009-12-31 $36
2009-09-30 $31
2009-06-30 $31
2009-03-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.578B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.391B 11.73
Quest Diagnostics (DGX) United States $16.058B 16.47
DaVita (DVA) United States $12.497B 15.52
Encompass Health (EHC) United States $9.126B 23.36
Chemed (CHE) United States $8.190B 25.03
Elanco Animal Health (ELAN) United States $6.335B 16.44
Option Care Health (OPCH) United States $5.388B 20.40
Amedisys (AMED) United States $3.194B 22.89
Astrana Health (ASTH) United States $2.939B 39.76
Addus HomeCare (ADUS) United States $2.192B 28.36
LifeStance Health (LFST) United States $2.118B 0.00
U.S Physical Therapy (USPH) United States $1.462B 39.11
Pennant (PNTG) United States $0.878B 46.37
Aveanna Healthcare Holdings (AVAH) United States $0.818B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00